GL1X · GenesisL1 explorer

Research workbench

TEG12 APO

Analyse TEG12 APO in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3MGC
Type
protein
Length
482 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
TEG12
EC
2.8.2.-
UniProt
B7T1D7
Ligands
PME
Pockets
2 · best druggability 0.58

Structure

x-ray diffraction · 2 distinct chains · 48% helix, 12% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATEG12 (EC 2.8.2.-)protein25545% helix, 11% strandB7T1D7
BTEG12 (EC 2.8.2.-)protein22750% helix, 12% strandB7T1D7

Ligands and binding sites

  • PME · N-L-alpha-aspartyl L-phenylalanine 1-methyl ester · ligand · chains A
  • GOL · Glycerol · additive · 3 copies · chains A
  • IMD · Imidazole · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13560.580.7638PME
22390.480.7427empty

Interfaces

1 interface between chains.

  • A–B · 610 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 3MGC · Teg12 Apo · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.